期刊文献+

长治地区结核分枝杆菌的耐多药性研究 被引量:3

Survey on multiple drug-resistance to mycrobacteria in Changzhi region
下载PDF
导出
摘要 目的分析长治地区结核分枝杆菌耐药性的特点,了解其耐多药菌的流行情况。方法采用分离培养,菌种鉴定。并对鉴定的结核分枝杆菌利用绝对浓度法进行耐药性测定。结果在长治地区500例结核病人的临床标本中,分离出结核分枝杆菌168株,阳性分离率为33.6%。168株结核分枝杆菌对14种抗痨药物的耐药性分别为:无耐药32株,为19.0%;耐1种药32株,为19.0%;耐2种药48株,为28.6%;耐3种药16株,为9.5%;耐4、5种药各4株,为2.4%;耐6、7、10种药各2株,为1.2%;耐8、9种药各4株,为2.4%;耐11种药18株,为10.7%。耐两种以上药104株,为59.9%;在168株中,农村分离菌株101株(60.1%),城镇67株(39.9%);在耐多药104菌株中,农村的为34株,为32.7%,城镇70株,为67.3%。结论长治地区耐多药性结核分枝杆菌所占比例较大,对结核病的流行产生严重的影响。农村的结核病发病率高于城镇,城镇的耐多药菌株高于农村。 Objective To survey the characteristics of drug-resistance to mycrobacteria in Changzhi region and find out the prevalence situation of multiple drug-resistant bacteria.Methods Mycrobacteria were isolated,cultured and identified.The drug-resistance of identified mycrobacteria was detected by absolute concentration method.Results Of clinical samples from 500 patients with tuberculosis in Changzhi region,mycrobacteria were isolated from 168 cases,and the positive rate was 33.6%.The resistance to 14 drugs of anti-tuberculosis in 168 strains was as follows:32 stains(19.0%)had no resistance to any drug;32(19.0%)resistant to one drug;48(28.6%)to two drugs;16(9.5%)to three drugs;4(2.4%)to four drugs,4(2.4%)to five drugs,4(2.4%)to eight drugs,4(2.4%)to nine drugs;and 2(1.2%)to six,2(1.2%)to seven,2(1.2%)to ten drugs;18(10.7%)to eleven drugs.In a word,59.9% of the 168 strains were resistant to more than two kinds of drugs.In all isolated mycrobacteria,101 strains(60.1%)were isolated from rural patients and 67(39.9%)from the urban.Among 104 strains of multiple drug-resistance,34(32.7%)were from the rural and 70(67.3%)from the urban.Conclusion The multiple drug-resistance mycrobacteria were superior in the Changzhi region,which results in more serious tuberculosis prevalence.The incidence of tuberculosis in the rural is higher than that in the urban,but drug-resistant strains from urban are more than ones from rural.
出处 《山西医科大学学报》 CAS 2007年第8期715-718,共4页 Journal of Shanxi Medical University
基金 山西省教育厅科技开发研究基金资助项目(20041242)
关键词 结核分枝杆菌 耐多药性 流行趋势 mycrobacteria multiple drug-resistance prevalence trend
  • 相关文献

参考文献8

二级参考文献18

  • 1胡忠义.结核病分子生物学研究的进展[J].临床肺科杂志,1998,3(5):7-9. 被引量:1
  • 2阚冠卿,张立兴,屠德华,蒋建英.积极开展结核菌原发耐药性趋势的连续观察[J].中国防痨杂志,1994,16(1):1-2. 被引量:23
  • 3吴雪琼,庄玉辉,何秀云,李国利,张晓刚.结核分支杆菌链霉素耐药基因的检测[J].中华结核和呼吸杂志,1996,19(6):342-345. 被引量:15
  • 4肖和平(译),结核病临床手册,1999年,105页
  • 5Luo C,Tuberc Lung Dis,1994年,75卷,110页
  • 6Bolmatrom A,Nordstrom U.E-test for drug combination studieswith mycobacteria. . 1995
  • 7Hausdorfer J.Sompek E,Allerberger F,et al.E-test for susceptibili-ty testing of Mycobacterium tuberculosis. International Journal of Tuberculosis and Lung Disease . 1998
  • 8Walters SB,Hanna BA.Testing of susceptibility of Mycobacteriumtubereulosis for isoniazid and rifampin by Mycobacteria growth indi-cator tube. Journal of Clinical Microbiology . 1996
  • 9Telenti A,Imboden P,Marchesi F,et al.Detection of rifampicin re-sistence mutations in Mycobaterium tuberculosis. The Lancet . 1993
  • 10Wanger A,Mills K.Testing of mycobacterium tuberculosis suscepti-bility to Ethambutol,Isoniazad,Rifampin and Streptomycin by usingE-test. Journal of Clinical Microbiology . 1996

共引文献1014

同被引文献23

  • 1Syed IH, Kristina J, Mats T, et al. Analysis of the association be- tween polypharmacy and socioeconomic position among elderly aged 77 years in Sweden[J]. Clin Ther,2008,30(2) :419 - 427.
  • 2Alessandro N,Alessandra M, Mauro T,et al. Association between clusters of diseases and polypharmacy in hospitalized elderly pa- tientsResults from the REPOSI study[J]. Eur J Inter Med, 2011, 22(6) :597 - 602.
  • 3Emily R, Hajjar, Angela C, et al. Polypharmacy in elderly patients [J]. Am J Geriatric Pharmacotherapy, 2007,5 (4) : 345 - 351.
  • 4Yesim GK, Anil B, Ayce A,et al. Polypharmacy in the Elderly: A Multicenter Study[J] J Am Med Dir Ass,2009,10(7) :486 - 490.
  • 5Catherine Y. Wing, Sarwat I,et al. Trends in comorbidity, disabili- ty, and polypharmaey in heart failure[J]. Am J Med, 2011,124 (2) :136 - 143.
  • 6Lynch P,Riedel AA, Fan Y, et al. PDB 69 Significant reduction in polypharmacy and health care utilization with insulin pump therapy (CSII)in patients type2 diabetes[J]. Value Health, 2009,12(7): A414.
  • 7Aparasu RR,Mort JR,Brandt H,et al.Polypharmacy trends in of-fice visits by the elderly in the United States,1990 and 2000[J].Research in Social and Administrative Pharmacy,2005,1(1):446-459.
  • 8Larsen PD,Martin JL.Polypharmacy and elderly patients[J].A-ORNJ,1999,69(3):619-628.
  • 9Emily RH,Angela CC,Joseph THA,et al.Polypharmacy in elderlypatients[J].The American Journal of Geriatric Pharmacotherapy,2007,5(4):345-351.
  • 10Syed Imran Haider,Kristina Johnell,Mats Thorslund,et al.Analysisof the association between polypharmacy and socioeconomic positionamong elderly aged≥77 years in Sweden[J].Clinical Therapeu-tics,2008,30(2):419-427.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部